We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$150M
AUM Growth
+$4.8M
Cap. Flow
-$568K
Cap. Flow %
-0.38%
Top 10 Hldgs %
31.49%
Holding
144
New
2
Increased
41
Reduced
60
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 23.23%
2 Financials 12.07%
3 Technology 11.49%
4 Industrials 10.14%
5 Consumer Staples 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIP icon
126
iShares TIPS Bond ETF
TIP
$14.5B
$227K 0.15%
2,001
-50
-2% -$5.71K
CB icon
127
Chubb
CB
$135B
$225K 0.15%
1,550
RDS.A
128
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$223K 0.15%
4,200
OPPJ
129
WisdomTree Trust WisdomTree Japan Opportunities Fund
OPPJ
$276M
$220K 0.15%
11,050
PNRA
130
DELISTED
Panera Bread Co
PNRA
$220K 0.15%
700
-300
-30% -$93.8K
FAST icon
131
Fastenal
FAST
$54.3B
$219K 0.15%
20,164
+320
+2% +$3.59K
MON
132
DELISTED
Monsanto Co
MON
$217K 0.14%
1,834
SO icon
133
Southern Company
SO
$109B
$216K 0.14%
4,514
TRP icon
134
TC Energy
TRP
$70.6B
$216K 0.14%
4,527
+93
+2% +$4.37K
SSB icon
135
SouthState Bank Corp
SSB
$10.2B
$209K 0.14%
2,440
+150
+7% +$13K
CL icon
136
Colgate-Palmolive
CL
$72.7B
$208K 0.14%
2,804
RJI
137
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Total Return
RJI
$132K 0.09%
26,950
-16,902
-39% -$83.2K
RJA
138
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Agriculture Total Return
RJA
$90K 0.06%
14,150
TEVA icon
139
Teva Pharmaceuticals
TEVA
$40.8B
-6,570
Closed -$211K
NXGN
140
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-10,157
Closed -$155K
PX
141
DELISTED
Praxair Inc
PX
-5,800
Closed -$688K

Similar funds

Roberts, Glore & Co's Q2 2017 Portfolio in Review

As of Q2 2017, Roberts, Glore & Co held 144 positions worth $150M, up 3.3% from $145M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 3.5%. Roberts, Glore & Co opened 2 new positions and exited 3, leaving the 144-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.

  • Roberts, Glore & Co's largest Q2 2017 buy was Perrigo: 4,400 shares worth $332K.
  • Roberts, Glore & Co added most to Western Asset Inflation-Linked Opportunities & Income Fund in Q2 2017, an estimated $997K increase.
  • Roberts, Glore & Co's biggest Q2 2017 reduction was Atrion Corp, cutting an estimated $415K.
  • Roberts, Glore & Co fully exited Praxair Inc in Q2 2017, selling an estimated $688K.
  • Roberts, Glore & Co's ten largest holdings make up 31% of its $150M portfolio in Q2 2017.
  • Roberts, Glore & Co opened 2 new positions and closed 3 in Q2 2017.
  • Roberts, Glore & Co's portfolio value rose 3.3% quarter-over-quarter to $150M.

Based on Roberts, Glore & Co's 13F filing for Q2 2017, filed 15 Aug 2017.